Back
HOOKIPA Pharma Quote, Financials, Valuation and Earnings
Sponsored
HOOK
Sponsored
Hint at where the next big move in the market will be this month
Spot the next big move with this free book from a hedge fund manager
Sell
20
HOOK
HOOKIPA Pharma
Last Price:
4.68
Seasonality Move:
-15.79%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmHOOKIPA Pharma Price Quote
$4.68
+0.06 (+1.3%)
(Updated: September 19, 2024 at 6:55 PM ET)
HOOKIPA Pharma Key Stats
Sell
20
HOOKIPA Pharma (HOOK)
is a Sell
Day range:
$4.56 - $4.90
52-week range:
$4.10 - $11.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.05
P/B ratio:
0.53%
Volume:
51K
Avg. volume:
23.6K
1-year change:
-28.37%
Market cap:
$45.7M
Revenue:
$20.1M
EPS:
$-4.32
How Much Does HOOKIPA Pharma Make?
-
How Much Are HOOKIPA Pharma's Sales Annually?
HOOK Revenues are $20.1M -
How Much Profit Does HOOKIPA Pharma's Make A Year?
HOOK net income is -$81.6M
Is HOOKIPA Pharma Growing As A Company?
-
What Is HOOKIPA Pharma's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.52% -
What Is HOOKIPA Pharma's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
HOOKIPA Pharma Stock Price Performance
-
Did HOOKIPA Pharma Stock Go Up Last Month?
HOOKIPA Pharma share price went down by -4.94% last month -
Did HOOK's Share Price Rise Over The Last Year?
HOOK share price fell by -28.37% over the past 1 year
What Is HOOKIPA Pharma 52-Week High & Low?
-
What Is HOOKIPA Pharma’s 52-Week High Share Price?
HOOKIPA Pharma has traded as high as $11.30 over the past 52 weeks -
What Is HOOKIPA Pharma’s 52-Week Low Share Price?
HOOKIPA Pharma has traded as low as $4.10 over the past 52 weeks
HOOKIPA Pharma Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy HOOKIPA Pharma?
-
How Much Debt Does HOOKIPA Pharma Have?
Total long term debt quarterly is $0 -
How Much Cash Does HOOKIPA Pharma Have?
Cash and short term investments quarterly total is $77.2M -
What Is HOOKIPA Pharma’s Book Value Per Share?
Book value per share is 8.70
Is HOOKIPA Pharma Cash Flow Positive?
-
What Is HOOK Cash Flow From Operations?
Cash flow from operations (TTM) is -$73.9M -
What Is HOOKIPA Pharma’s Cash Flow From Financing?
Cash flow from financing (TTM) is $19.3M -
What Is HOOKIPA Pharma’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$3.6M
HOOKIPA Pharma Return On Invested Capital
-
Is Management Doing A Good Job?
HOOK return on invested capital is -49.37% -
What Is HOOKIPA Pharma Return On Assets?
ROA measures how assets are converting to revenues and is -30.86% -
What Is HOOK Return On Equity?
ROE is a measure of profitability and is -49.81%
HOOKIPA Pharma Earnings Date & Stock Price
-
What Is HOOKIPA Pharma's Stock Price Today?
A single share of HOOK can be purchased today for 4.62 -
What Is HOOKIPA Pharma’s Stock Symbol?
HOOKIPA Pharma trades on the nasdaq under the ticker symbol: HOOK -
When Is HOOKIPA Pharma’s Next Earnings Date?
The next quarterly earnings date for HOOKIPA Pharma is scheduled on November 8, 2024 -
When Is HOOK's next ex-dividend date?
HOOKIPA Pharma's next ex-dividend date is May 26, 2020 -
How To Buy HOOKIPA Pharma Stock?
You can buy HOOKIPA Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
HOOKIPA Pharma Competitors
-
Who Are HOOKIPA Pharma's Competitors?
Below is a list of companies who compete with HOOKIPA Pharma or are related in some way:
HOOKIPA Pharma Dividend Yield
-
What Is HOOK Dividend Yield?
HOOKIPA Pharma’s dividend yield currently is 0% -
What Is HOOKIPA Pharma’s Payout Ratio?
HOOKIPA Pharma’s payout ratio is 0% -
When Did HOOKIPA Pharma Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is HOOKIPA Pharma’s Dividend Per Share?
HOOKIPA Pharma pays a dividend of $0.00 per share
HOOKIPA Pharma Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -21.01% |
Revenue: | -51.85% | -81.81% |
Analyst Recommendations
Buy Recommendations: | 1 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 43.50 |
Upside from Last Price: | 841.56% |